On Nov 3, 2021 ANI Pharmaceuticals closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: ANI Pharmaceuticals […]
Series C – Wellinks
On Nov 3, 2021 Wellinks closed a Series C round and raised $25,000,000 from Benslie Investment Group, Connecticut Innovations, HighCape Partners, Morningside Ventures, Stonehenge Capital, […]
Seed Round – Ruth Health (YC S21)
On Nov 3, 2021 Ruth Health (YC S21) closed a Seed round and raised $2,390,000 from investors, featuring lead investors . About the company: Ruth […]
Series B – Hallow
On Nov 3, 2021 Hallow closed a Series B round and raised $40,000,000 from Contrary, Drive Capital, Narya Capital, Peter Thiel, Scott Malpass, Susa Ventures, […]
Series B – Notable
On Nov 3, 2021 Notable closed a Series B round and raised $100,000,000 from F-Prime Capital, Greylock, ICONIQ Growth, Oak HC/FT, featuring lead investors ICONIQ […]
Series C – Biond Biologics
On Nov 3, 2021 Biond Biologics closed a Series C round and raised $15,000,000 from Deep Insight, Harel Insurance Investments and Financial Services, Heritage Group, […]
Series B – BrainCheck
On Nov 3, 2021 BrainCheck closed a Series B round and raised $10,000,000 from Next Coast Ventures, Nueterra Capital, S3 Ventures, SelectQuote Insurance Services, Tensility […]
Seed Round – Dogsee Chew
On Nov 3, 2021 Dogsee Chew closed a Seed round and raised $7,000,000 from Sixth Sense Ventures, featuring lead investors Sixth Sense Ventures. About the […]
Venture Round – Illumigyn
On Nov 3, 2021 Illumigyn closed a Venture – Series Unknown round and raised $33,000,000 from Ubicom Holdings, Yozma Group, featuring lead investors Ubicom Holdings, […]
Series A – Nitrase Therapeutics
On Nov 2, 2021 Nitrase Therapeutics closed a Series A round and raised $7,000,000 from AbbVie Biotech Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Dementia […]
